An Interview With John MacMahon, CEO of CytoKind, on the Benefits of Artificial Sunlight

from Rare Care Podcast · host Rare Disease Advisor

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews John MacMahon, a New Hampshire-based medical devices company that specializes in phototherapy to treat fatigue in people with multiple sclerosis.

Episode metadata supplied by the publisher feed · Published Jul 6, 2026

Embed this episode

Attribution link and audio player

Ready to play

An Interview With John MacMahon, CEO of CytoKind, on the Benefits of Artificial Sunlight

0:00 16:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Rare Care Podcast?

This episode is 16 minutes long.

When was this Rare Care Podcast episode published?

This episode was published on July 6, 2026.

Can I download this Rare Care Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!